Japan Colorectal Cancer Screening Market Insight
Japan Colorectal Cancer Screening market size is growing at a 5.24%, driven by increasing prevalence of colorectal cancer, rising awareness of early detection, and strong government-led screening programs.
Japan Colorectal Cancer Screening Market Insights Forecasts to 2035
- The Japan Colorectal Cancer Screening Market Size Was Estimated at USD 570.34 Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 5.24% from 2025 to 2035
- The Japan Colorectal Cancer Screening Market Size is Expected to Reach USD 950.2 Million by 2035
Notable Insights for Japan Colorectal Cancer Screening Market
- By test type, the fecal occult blood test (FOBT/FIT) segment dominated the market, accounting for over 55% share, driven by its widespread use in national screening programs and cost-effectiveness.
- By test type, the biomarker and DNA-based screening segment is expected to witness the fastest growth, supported by increasing adoption of advanced molecular diagnostics, with growth projected at over 14% CAGR.
- Approximately hospitals and clinics account for over 50% of screening activities, while home-based testing adoption is increasing with rising demand for convenient and non-invasive diagnostic solutions.
- Government initiatives are significantly strengthening the market, as Japan’s National Cancer Screening Program provides annual screening for individuals aged 40 and above using FIT kits, with over 15 million screening kits distributed annually and participation rates improving to around 48.7% in recent years.
Download the eBook (ToC)
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the Japan Colorectal Cancer Screening market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in Japan Colorectal Cancer Screening Market
- Sysmex Corporation
- Fujirebio
- Eiken Chemical
- Abbott Laboratories
- Siemens Healthineers
- Roche
- Danaher Corporation
- Others
Recent Developments:
- In March 2026, Sysmex Corporation expanded its advanced diagnostic solutions for colorectal cancer screening, focusing on high-sensitivity testing technologies.
- In October 2025, Fujirebio introduced innovative biomarker-based screening assays to improve early detection accuracy and efficiency.
Market Segmentation:
Japan Colorectal Cancer Screening Market, By Test Type
- Fecal Occult Blood Test (FOBT/FIT)
- Colonoscopy
- Sigmoidoscopy
- Biomarker / DNA Tests
Japan Colorectal Cancer Screening Market, By Application
- Hospitals & Clinics
- Diagnostic Laboratories
- Home Care
Japan Colorectal Cancer Screening Market, By End User
- Healthcare Providers
- Diagnostic Centers
- Research Institutes
Expert Views:
The Japan Colorectal Cancer Screening Market is poised for steady growth, driven by increasing cancer incidence and strong government screening programs. Experts highlight that FIT-based screening will dominate, while biomarker-based and non-invasive screening technologies will witness the fastest growth, ensuring improved early detection and reduced mortality rates.